Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer. - Katayama K; Yoshikawa N; Liu W; Nakamura K; Hattori S; Kubokawa M; Iyoshi S; Yoshida K; Yoshihara M; Nagao Y; Tamauchi S; Yokoi A; et al. (Cancer immunology, immunotherapy : CII, 2026)